ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $724,796 | +236.4% | 228,642 | +427.5% | 0.00% | – |
| Q2 2023 | $215,431 | -90.0% | 43,346 | -90.0% | 0.00% | -100.0% |
| Q1 2023 | $2,149,000 | +1480.1% | 435,020 | +3354.5% | 0.01% | – |
| Q3 2022 | $136,000 | -99.0% | 12,593 | -98.7% | 0.00% | -100.0% |
| Q4 2021 | $14,153,000 | +18.9% | 948,624 | +107.8% | 0.03% | -51.9% |
| Q2 2021 | $11,908,000 | +364.1% | 456,591 | +245.9% | 0.05% | +107.7% |
| Q1 2020 | $2,566,000 | -35.5% | 132,006 | -13.8% | 0.03% | -3.7% |
| Q4 2019 | $3,977,000 | +657.5% | 153,105 | +684.2% | 0.03% | +575.0% |
| Q2 2019 | $525,000 | -85.3% | 19,524 | -84.2% | 0.00% | -76.5% |
| Q1 2019 | $3,564,000 | – | 123,284 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |